Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
George Washington University
Study ID
NCT07787247
Status
Recruiting
Apply to this trial

Conditions

  • Myasthenia Gravis (MG)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the monitoring program

Key Dates

First listed
Aug 26, 2026
Start date
Aug 19, 2026
Status verified
Aug 2026
Primary completion
Oct 31, 2028
Completion
Oct 31, 2028

Study Design

Enrollment
18 participants (estimated)

Primary Outcome Measure

Subject Study Completion [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
The George Washington UniversityWashington D.C.District of Columbia20037
Gulsen Oztosun, M.D.
[email protected]
202-677-6109
Henry J Kaminski, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Washington D.C., DC

By research site
The George Washington University· Washington D.C., DC

Related Studies